(SUSM) iShares MSCI EM SRI USD - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00BYVJRP78 • Global Emerging Markets Equity

SUSM: Stocks, Bonds, Emerging Markets, Sustainable Investments

The iShares MSCI EM SRI UCITS ETF USD (Acc) CHF (SW:SUSM) is an exchange-traded fund managed by BlackRock, one of the worlds largest asset managers. The fund is domiciled in Ireland, a common choice for European ETFs due to its favorable regulatory environment and tax efficiencies for cross-border distributions.

The ETF tracks the Morningstar EM TME NR USD index, which focuses on emerging markets equities with a sustainability tilt. Morningstar, the index provider, incorporates ESG (Environmental, Social, and Governance) criteria to exclude companies involved in controversial activities such as fossil fuels, nuclear power, and weapons. This makes the fund appealing to investors seeking exposure to emerging markets with a sustainable and responsible investment approach.

From a structural standpoint, the fund is a UCITS-compliant ETF, meaning it adheres to the European Unions Undertakings for the Collective Investment in Transferable Securities framework. This ensures transparency, liquidity, and investor protection. The fund is listed on the SIX Swiss Exchange under the ticker SUSM and is denominated in Swiss Francs, making it accessible to Swiss and European investors.

As of recent data, the fund has approximately $2.896 billion in assets under management (AUM), indicating significant investor interest in its sustainable emerging markets strategy. The ETF employs a replication strategy, meaning it aims to track the index as closely as possible, typically through direct holdings of the underlying securities. This approach minimizes tracking error and ensures that investors gain exposure to the targeted assets.

From an investment perspective, the fund offers a way to access emerging markets equities while aligning with ESG principles. Emerging markets are a key driver of global growth, and this ETF provides a diversified exposure across regions and sectors. However, investors should be aware of the inherent risks associated with emerging markets, including political instability, currency volatility, and liquidity risks.

Additional Sources for SUSM ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SUSM ETF Overview

Market Cap in USD 2,862m
Category Global Emerging Markets Equity
TER 0.25%
IPO / Inception 2016-07-11

SUSM ETF Ratings

Growth 5y 24.7%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -0.97
Analysts -
Fair Price Momentum 6.57 USD
Fair Price DCF -

SUSM Dividends

No Dividends Paid

SUSM Growth Ratios

Growth Correlation 3m -0.4%
Growth Correlation 12m 71.1%
Growth Correlation 5y -17.7%
CAGR 5y 8.38%
CAGR/Max DD 5y 0.23
Sharpe Ratio 12m 0.75
Alpha -0.36
Beta 0.65
Volatility 20.05%
Current Volume 6k
Average Volume 20d 9.9k
What is the price of SUSM stocks?
As of March 14, 2025, the stock is trading at USD 7.32 with a total of 6,022 shares traded.
Over the past week, the price has changed by -1.13%, over one month by -1.77%, over three months by -3.06% and over the past year by +5.38%.
Is iShares MSCI EM SRI USD a good stock to buy?
Neither. Based on ValueRay Analyses, iShares MSCI EM SRI USD is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.71 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SUSM as of March 2025 is 6.57. This means that SUSM is currently overvalued and has a potential downside of -10.25%.
Is SUSM a buy, sell or hold?
iShares MSCI EM SRI USD has no consensus analysts rating.
What are the forecast for SUSM stock price target?
According to ValueRays Forecast Model, SUSM iShares MSCI EM SRI USD will be worth about 7.3 in March 2026. The stock is currently trading at 7.32. This means that the stock has a potential downside of -0.41%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 7.3 -0.4%